Ocean Biomedical Financials
| OCEA Stock | 0.06 0 2.30% |
Ocean |
Please note, the presentation of Ocean Biomedical's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Ocean Biomedical's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Ocean Biomedical's management manipulating its earnings.
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | US67644C1045 |
| CUSIP | 67644C104 00809L106 |
| Location | New York; U.S.A |
| Business Address | 55 Claverick Street, |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.oceanbiomedical.com |
| Phone | 401 444 7375 |
Ocean Biomedical Key Financial Ratios
| Return On Asset | -6.82 | ||||
| Target Price | 18.5 | ||||
| Beta | 1.53 |
Ocean Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Ocean Biomedical's current stock value. Our valuation model uses many indicators to compare Ocean Biomedical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Ocean Biomedical competition to find correlations between indicators driving Ocean Biomedical's intrinsic value. More Info.Ocean Biomedical is rated below average in return on asset category among its peers. It is regarded second in current valuation category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Ocean Biomedical's earnings, one of the primary drivers of an investment's value.Ocean Biomedical Systematic Risk
Ocean Biomedical's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Ocean Biomedical volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Ocean Biomedical correlated with the market. If Beta is less than 0 Ocean Biomedical generally moves in the opposite direction as compared to the market. If Ocean Biomedical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Ocean Biomedical is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Ocean Biomedical is generally in the same direction as the market. If Beta > 1 Ocean Biomedical moves generally in the same direction as, but more than the movement of the benchmark.
About Ocean Biomedical Financials
What exactly are Ocean Biomedical Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Ocean Biomedical's income statement, its balance sheet, and the statement of cash flows. Potential Ocean Biomedical investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Ocean Biomedical investors may use each financial statement separately, they are all related. The changes in Ocean Biomedical's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Ocean Biomedical's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.Ocean Biomedical March 21, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Ocean Biomedical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Ocean Biomedical. We use our internally-developed statistical techniques to arrive at the intrinsic value of Ocean Biomedical based on widely used predictive technical indicators. In general, we focus on analyzing Ocean Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Ocean Biomedical's daily price indicators and compare them against related drivers.
| Information Ratio | (0.33) | |||
| Maximum Drawdown | 51.0 | |||
| Value At Risk | (15.19) | |||
| Potential Upside | 15.38 |
Complementary Tools for Ocean Stock analysis
When running Ocean Biomedical's price analysis, check to measure Ocean Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ocean Biomedical is operating at the current time. Most of Ocean Biomedical's value examination focuses on studying past and present price action to predict the probability of Ocean Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ocean Biomedical's price. Additionally, you may evaluate how the addition of Ocean Biomedical to your portfolios can decrease your overall portfolio volatility.
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |